Cell Therapy Packaging Market

Chapter Outlines

Chapter 2 is an executive summary of the key insights captured in our research. It offers a high-level view on the current state of cell therapy packaging providers market and its likely evolution in the short-mid to long term.

Chapter 3 provides a general introduction to the pharmaceutical filling and packaging, including information on types of pharmaceutical packaging. The chapter lays emphasis on cell therapy packaging, primary and secondary packaging of cell therapies. In addition, it discusses the key considerations and challenges associated with cell therapy packaging.

Chapter 4 features an overview of the current market landscape of cell therapy packaging services providers, including a detailed analysis on the year of establishment, company size and location of headquarters. In addition, the chapter highlights the analysis on the package engineering design (primary and secondary), type of packaging (active and passive), packaging material (dry ice and liquid nitrogen) and type of passive system used. Further, the chapter also presents analysis on temperature ranges supported, type of cells handled and additional services offered.

Chapter 5 presents a detailed assessment of the current market landscape of cell therapy packaging products, providing information on type of packaging container (bags, vials, shipping container and others), container fabrication material (plastic and others), storage temperature conditions, type of cells packed and usability of containers. In addition, the chapter highlights analysis of cell therapy packaging product provider(s), based on various parameters such as year of establishment, company size and location of headquarters and key players.

Chapter 6 includes profiles of the key players offering cell therapy packaging services and products. Each profile includes a brief overview of the company, details on cell therapy service portfolio, information on cell therapy packaging product portfolio, recent developments and an informed future outlook.

Chapter 7 presents in-depth competitiveness analysis of cell therapy packaging service providers based in different geographies, by taking into consideration the service strength of a company (based on its experience), packaging portfolio (package engineering design, type of packaging, type of packaging material and temperature ranges supported) service portfolio (type of additional services offered) and company size (small, mid-sized and large companies).

Chapter 8 provides an analysis of the various partnerships established  between cell therapy packaging providers and cell therapy developers, during the period, 2016-2021. It includes a brief description of various types of partnership models (namely service alliance, technology / platform integration agreement, merger and acquisition) adopted by stakeholders engaged in this domain. It is worth mentioning that the data captured during our research was analyzed based on several parameters, such as year of partnership, type of partnership, purpose of partnership, type of service covered and geographical location of players involved in a partnership.

Chapter 9 presents a list of more than 250 cell therapy developers anticipated to partner with cell therapy packaging providers, which have been shortlisted on the basis of developer strength (based on company size), type of therapy and pipeline maturity (based on stage of development of drug candidate).

Chapter 10 features a case study highlighting the companies that claim to have the required expertise and capabilities for development and manufacturing of cell therapies, along with the information on their year of establishment, company size, location of headquarters and location of manufacturing facility. In addition, the chapter  presents analysis on type of cells manufactured, source of cells, scale of operation and manufacturing capabilities / services of the aforementioned companies.

Chapter 11 presents a detailed market forecast analysis, providing insights on the likely growth of continuous manufacturing equipment providers market for the period 2021-2030. In addition, the chapter presents the likely distribution of the projected future opportunity based on type of therapy (T-cell therapies, dendritic cell vaccines, stem cell therapies, NK cell therapies and other advanced therapy medicinal products), package engineering design (primary and secondary packaging), scale of operation (clinical and commercial) and geography (North America, Europe, Asia Pacific and Rest of the World).

Chapter 12  is a summary of the overall report, which presents the insights on the contemporary market trends and the likely evolution of cell therapy products and services market. 

Chapter 13 is an appendix that contains tabulated data and numbers for all the figures provided in the report.

Chapter 14 is an appendix that provides the list of companies and organizations mentioned in the report.

Table Of Contents

1. PREFACE
1.1. Scope of the Report
1.2. Research Methodology
1.3. Key Questions Answered
1.4. Chapter Outlines

2. EXECUTIVE SUMMARY

3. INTRODUCTION
3.1. Chapter Overview 
3.2. Pharmaceutical Filling and Packaging
3.3. Importance of Pharmaceutical Packaging
3.4. Types of Pharmaceutical Packaging
3.5. Packaging of Cell Therapies
3.5.1. Primary Packaging 
3.5.2. Secondary Packaging

3.6. Cell Therapy Packaging: Key Considerations
3.7. Challenges associated with Cell Therapy Packaging
3.8. Concluding Remarks

4. CELL THERAPY PACKAGING SERVICE PROVIDERS: MARKET LANDSCAPE
4.1. Chapter Overview
4.2. Cell Therapy Packaging Service Providers Market Landscape
4.2.1. Analysis by Year of Establishment
4.2.2. Analysis by Company Size
4.2.3. Analysis by Location of Headquarters
4.2.4. Analysis by Package Engineering Design
4.2.5. Analysis by Type of Packaging
4.2.6. Analysis by Type of Packaging Material
4.2.7. Analysis by Type of Passive System Used
4.2.8. Analysis by Temperature Ranges Supported
4.2.9. Analysis by Type of Cells Handled
4.2.10. Analysis by Type of Additional Service(s) Offered
4.2.11. Logo Landscape: Key Players offering Additional Services

5. CELL THERAPY PACKAGING PRODUCT PROVIDERS: MARKET LANDSCAPE
5.1. Chapter Overview
5.2. Cell Therapy Packaging Products: Market Landscape
5.2.1. Analysis by Type of Packaging Container
5.2.2. Analysis by Container Fabrication Material
5.2.3. Analysis by Type of Packaging Container and Container Fabrication Material
5.2.4. Analysis by Storage Temperature Conditions
5.2.5. Analysis by Type of Packaging Container and Storage Temperature Conditions
5.2.6. Analysis by Type of Cells Packed
5.2.7. Analysis by Usability of Container

5.3. Cell Therapy Packaging Product Providers
5.3.1. Analysis by Year of Establishment
5.3.2. Analysis by Company Size
5.3.3. Analysis by Location of Headquarters

6. CELL THERAPY PACKAGING SERVICE AND PRODUCT PROVIDERS: COMPANY PROFILES
6.1. Chapter Overview
6.2 Cell Therapy Packaging Service Providers
6.2.1. Almac
6.2.1.1. Company Overview
6.2.1.2. Cell Therapy Service Portfolio
6.2.1.3. Recent Developments and Future Outlook

6.2.2. Catalent Pharma Solutions
6.2.2.1. Company Overview
6.2.2.2. Cell Therapy Service Portfolio
6.2.2.3. Recent Developments and Future Outlook
6.2.3. Cryoport Systems
6.2.3.1. Company Overview
6.2.3.2. Cell Therapy Service Portfolio
6.2.3.3. Recent Developments Future Outlook

6.2.4. Yourway
6.2.4.1. Company Overview
6.2.4.2. Cell Therapy Service Portfolio
6.2.4.3. Recent Developments and Future Outlook

6.3. Cell Therapy Packaging Product Providers
6.3.1. Lufthansa Cargo
6.3.1.1. Company Overview
6.3.1.2. Cell Therapy Packaging Product Portfolio
6.3.1.3. Recent Developments and Future Outlook

6.3.2. Saint-Gobain Life Sciences
6.3.2.1. Company Overview
6.3.2.2. Cell Therapy Packaging Product Portfolio
6.3.2.3. Recent Developments and Future Outlook

6.3.3. Thermo Fisher Scientific
6.3.3.1. Company Overview
6.3.3.2. Cell Therapy Packaging Product Portfolio
6.3.3.3. Recent Developments and Future Outlook

6.3.4. West Pharmaceutical Services
6.3.4.1. Company Overview
6.3.4.2. Cell Therapy Packaging Product Portfolio
6.3.4.3. Recent Developments and Future Outlook

7. COMPANY COMPETITIVENESS ANALYSIS
7.1. Chapter Overview
7.2. Methodology and Key Input Parameters
7.3. Cell Therapy Packaging Service Providers
7.3.1. Companies based in North America
7.3.2. Companies based in Europe and Asia Pacific

8. PARTNERSHIPS AND COLLABORATIONS
8.1. Chapter Overview
8.2. Partnership Models
8.3. Cell Therapy Packaging: List of Partnerships and Collaborations
8.3.1. Analysis by Year of Partnership
8.3.2. Analysis by Type of Partnership
8.3.3. Analysis by Year and Type of Partnership
8.3.4. Analysis by Purpose of Partnership
8.3.5. Analysis by Type of Service(s) Covered
8.3.6. Most Active Players: Analysis by Number of Partnerships
8.3.7. Regional Analysis
8.3.8. Intercontinental and Intracontinental Agreements

9. LIKELY PARTNER ANALYSIS
9.1. Chapter Overview
9.2. Scope and Methodology
9.3. Potential Strategic Partners for Cell Therapy Packaging Providers in North America
9.3.1. Most Likely Partners
9.3.2. Likely Partners
9.3.3. Less Likely Partners

9.4. Potential Strategic Partners for Cell Therapy Packaging Providers in Europe
9.4.1. Most Likely Partners
9.4.2. Likely Partners
9.4.3. Less Likely Partners

9.5. Potential Strategic Partners for Cell Therapy Packaging Providers in Asia Pacific and Rest of the World
9.5.1. Most Likely Partners
9.5.2. Likely Partners
9.5.3. Less Likely Partners

10. CELL THERAPY DEVELOPERS AND MANUFACTURERS: CASE STUDY
10.1. Chapter Overview
10.2. Cell Therapy Manufacturers: Overall Market Landscape
10.2.1. Analysis by Year of Establishment
10.2.2. Analysis by Company Size
10.2.3. Analysis by Location of Headquarters
10.2.4. Analysis by Location of Manufacturing Facility
10.2.5. Analysis by Type of Cell(s) Manufactured
10.2.6. Analysis by Source of Cells
10.2.7. Analysis by Scale of Operation
10.2.8. Analysis by Manufacturing Capabilities / Services
10.2.9. Concluding Remarks

11. MARKET SIZING AND OPPORTUNITY ANALYSIS
11.1. Chapter Overview
11.2. Key Assumptions and Forecast Methodology
11.3 Global Cell Therapy Packaging Services Market, 2021-2030
11.4 Cell Therapy Packaging Services Market, 2021-2030: Distribution by Type of Cell Therapy
11.4.1. Cell Therapy Packaging Services Market for T-Cell Therapies, 2021-2030
11.4.2. Cell Therapy Packaging Services Market for Dendritic Cell Vaccines, 2021-2030
11.4.3. Cell Therapy Packaging Services Market for Stem Cell Therapies, 2021-2030
11.4.4. Cell Therapy Packaging Services Market for NK Cell Therapies, 2021-2030
11.4.5. Cell Therapy Packaging Services Market for Other Advanced Therapy Medical Products, 2021-2030

11.5. Cell Therapy Packaging Services Market, 2021-2030: Distribution by Package Engineering Design
11.5.1. Cell Therapy Packaging Services Market for Primary Packaging, 2021-2030
11.5.2. Cell Therapy Packaging Services Market for Secondary Packaging, 2021-2030

11.6. Cell Therapy Packaging Services Market, 2021-2030: Distribution by Scale of Operation
11.6.1. Cell Therapy Packaging Services Market for Clinical Scale Operations, 2021-2030
11.6.2. Cell Therapy Packaging Services Market for Commercial Scale Operations, 2021-2030

11.7. Cell Therapy Packaging Services Market, 2021-2030: Distribution by Geographical Regions
11.7.1. Cell Therapy Packaging Services Market in North America, 2021-2030
11.7.2. Cell Therapy Packaging Services Market in Europe, 2021-2030
11.7.3. Cell Therapy Packaging Services Market in Asia Pacific, 2021-2030
11.7.4. Cell Therapy Packaging Services Market in Rest of the World, 2021-2030

12. CONCLUDING REMARKS
12.1. Chapter Overview

13. APPENDIX 1: TABULATED DATA

14. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS

List Of Figures

Figure 3.1 Traditional Aseptic Pharmaceutical Filling
Figure 3.2 Advantages of Pharmaceutical Packaging
Figure 3.3 Types of Pharmaceutical Packaging
Figure 3.4 Packaging Containers for Cell Therapies
Figure 3.5 Challenging aspects of Cell Therapy Packaging
Figure 4.1 Cell Therapy Packaging Service Providers: Distribution by Year of Establishment
Figure 4.2 Cell Therapy Packaging Service Providers: Distribution by Company Size
Figure 4.3 Cell Therapy Packaging Service Providers: Distribution by Location of Headquarters
Figure 4.4 Cell Therapy Packaging Service Providers: Distribution by Package Engineering Design
Figure 4.5 Cell Therapy Packaging Service Providers: Distribution by Type of Packaging
Figure 4.6 Cell Therapy Packaging Service Providers: Distribution by Packaging Material
Figure 4.7 Cell Therapy Packaging Service Providers: Distribution by Type of Packaging and Packaging Material
Figure 4.8 Cell Therapy Packaging Service Providers: Distribution by Type of Passive System Used
Figure 4.9 Cell Therapy Packaging Service Providers: Distribution by Temperature Ranges Supported
Figure 4.10 Cell Therapy Packaging Service Providers: Distribution by Type of Packaging, Packaging Material and Temperature Ranges Supported
Figure 4.11 Cell Therapy Packaging Service Providers: Distribution by Type of Cells Handled
Figure 4.12 Cell Therapy Packaging Service Providers: Distribution by Type of Additional Service(s) Offered
Figure 4.13 Logo landscape: Key Players Offering Additional Services
Figure 5.1 Cell Therapy Packaging Products: Distribution by Type of Packaging Container
Figure 5.2 Cell Therapy Packaging Products: Distribution by Container Fabrication Material
Figure 5.3 Cell Therapy Packaging Products: Distribution by Type of Packaging Container and Container Fabrication Material
Figure 5.4 Cell Therapy Packaging Products: Distribution by Storage Temperature Conditions
Figure 5.5 Cell Therapy Packaging Products: Distribution by Type of Packaging Container and Storage Temperature Conditions
Figure 5.6 Cell Therapy Packaging Products: Distribution by Type of Cells Packed
Figure 5.7 Cell Therapy Packaging Products: Distribution by Usability of Container
Figure 5.8 Cell Therapy Packaging Product Providers: Distribution by Year of Establishment
Figure 5.9 Cell Therapy Packaging Product Providers: Distribution by Company Size
Figure 5.10 Cell Therapy Packaging Product Providers: Distribution by Location of Headquarters
Figure 5.11 Key Players: Analysis by Number of Cell Therapy Packaging Products
Figure 6.1 Almac: Cell Therapy Service Portfolio
Figure 6.2 Catalent Pharma Solutions: Cell Therapy Service Portfolio
Figure 6.3 Cryoport Systems: Cell Therapy Service Portfolio
Figure 6.4 Yourway: Cell Therapy Service Portfolio
Figure 7.1 Company Competitiveness Analysis: Cell Therapy Packaging Service Providers based in North America
Figure 7.2 Company Competitiveness Analysis: Cell Therapy Packaging Service Providers based in Europe and Asia-Pacific
Figure 8.1 Partnerships and Collaborations: Cumulative Year-wise Trend, 2016-2021
Figure 8.2 Partnerships and Collaborations: Distribution by Type of Partnership
Figure 8.3 Partnerships and Collaborations: Distribution by Year and Type of Partnership, 2016-2021 (till April)
Figure 8.4 Partnerships and Collaborations: Distribution by Purpose of Partnership
Figure 8.5 Partnerships and Collaborations: Distribution by Type of Service(s) Covered
Figure 8.6 Most Active Players: Distribution by Number of Partnerships
Figure 8.7 Partnerships and Collaborations: Distribution by Location of Parent Company
Figure 8.8 Partnerships and Collaborations: Distribution by Location of Partner Company
Figure 8.9 Partnerships and Collaborations: Intercontinental and Intracontinental Agreements
Figure 10.1 Cell Therapy Manufacturers: Distribution by Year of Establishment
Figure 10.2 Cell Therapy Manufacturers: Distribution by Company Size
Figure 10.3 Cell Therapy Manufacturers: Distribution by Location of Headquarters
Figure 10.4 Cell Therapy Manufacturers: Distribution by Location of Headquarters (Country Wise)
Figure 10.5 Cell Therapy Manufacturers: Distribution by Location of Manufacturing Facility (Region-wise)
Figure 10.6 Cell Therapy Manufacturers: Distribution by Location of Manufacturing Facility (Country-wise)
Figure 10.7 Cell Therapy Manufacturers: Distribution by Type of Cells Manufactured
Figure 10.8 Cell Therapy Manufacturers: Distribution by Type of Manufacturers
Figure 10.9 Cell Therapy Manufacturers: Distribution by Source of Cells
Figure 10.10 Cell Therapy Manufacturers: Distribution by Scale of Operation
Figure 10.11 Cell Therapy Manufacturers: Distribution by Manufacturing Capabilities / Services
Figure 11.1 Global Cell Therapy Packaging Services Market, 2021-2030 (USD Million)
Figure 11.2 Cell Therapy Packaging Services Market for T -Cell based Therapies, 2021-2030 (USD Million)
Figure 11.3 Cell Therapy Packaging Services Market for Dendritic Cell Vaccines, 2021-2030 (USD Million)
Figure 11.4 Cell Therapy Packaging Services Market for Stem Cell Therapies, 2021-2030 (USD Million)
Figure 11.5 Cell Therapy Packaging Services Market for NK Cell Therapies, 2021-2030 (USD Million)
Figure 11.6 Cell Therapy Packaging Services Market for Other Advanced Therapy Medicinal Products, 2021-2030 (USD Million)
Figure 11.7 Cell Therapy Packaging Services Market for Primary Packaging, 2021-2030 (USD Million)
Figure 11.8 Cell Therapy Packaging Services Market for Secondary Packaging, 2021-2030 (USD Million)
Figure 11.9 Cell Therapy Packaging Services Market for Clinical Scale Operations, 2021-2030 (USD Million)
Figure 11.10 Cell Therapy Packaging Services Market for Commercial Scale Operations, 2021-2030 (USD Million)
Figure 11.11 Cell Therapy Packaging Services Market in North America, 2021-2030 (USD Million)
Figure 11.12 Cell Therapy Packaging Services Market in Europe, 2021-2030 (USD Million)
Figure 11.13 Cell Therapy Packaging Services Market in Asia- Pacific, 2021-2030 (USD Million)
Figure 11.14 Cell Therapy Packaging Services Market in Rest of the World, 2021-2030 (USD Million)
Figure 12.1 Conclusion

List Of Tables

Table 4.1    Cell Therapy Packaging Service Providers
Table 4.2    Cell Therapy Packaging Service Providers: Information on Package Engineering Design, Type of Packaging, Packaging Material and Type of Passive System Used
Table 4.3    Cell Therapy Packaging Service Providers: Information on Temperature Ranges Supported and Type of Cells Handled
Table 4.4    Cell Therapy Packaging Service Providers: Information on Additional Services Offered
Table 5.1    Cell Therapy Packaging Products: Information on Type of Packaging Container and Container Fabrication Material
Table 5.2    Cell Therapy Packaging Products: Information on Storage Temperature Conditions, Packaging Volume, Type of Cells Stored and Availability of Single-use Product
Table 5.3    Cell Therapy Packaging Product Providers: List of Industry Players
Table 6.1    Cell Therapy Packaging Service and Product Providers: List of Companies Profiled
Table 6.2    Almac: Company Snapshot
Table 6.3    Almac: Recent Developments and Future Outlook
Table 6.4    Cryoport Systems: Company Snapshot
Table 6.5    Cryoport Systems: Recent Developments and Future Outlook
Table 6.6    Catalent Pharma Solutions: Company Snapshot
Table 6.7    Catalent Pharma Solutions: Recent Developments and Future Outlook
Table 6.8    Yourway: Company Snapshot
Table 6.9    Lufthansa Cargo: Company Snapshot
Table 6.10    Lufthansa Cargo: Product Portfolio
Table 6.11    Lufthansa Cargo: Recent Developments and Future Outlook
Table 6.12    Saint-Gobain Life Sciences: Company Snapshot
Table 6.13    Saint-Gobain Life Sciences: Product Portfolio
Table 6.14    Thermo Fisher Scientific: Company Snapshot
Table 6.15    Thermo Fisher Scientific: Product Portfolio
Table 6.16    Thermo Fisher Scientific: Recent Developments and Future Outlook
Table 6.17    West Pharmaceutical Services: Company Snapshot
Table 6.18    West Pharmaceutical Services: Product Portfolio
Table 6.19    West Pharmaceutical Services: Recent Developments and Future Outlook
Table 7.1    Cell Therapy Packaging: List of Partnerships and Collaborations, 2016-2021
Table 7.2    Partnerships and Collaborations: Information on Type of Service(s) Covered
Table 9.1    Most Likely Partners for Cell Therapy Packaging Product and Service Providers in North America
Table 9.2    Likely Partners for Cell Therapy Packaging Product and Service Providers in North America
Table 9.3    Less Likely Partners for Cell Therapy Packaging Product and Service Providers in North America
Table 9.4    Most Likely Partners for Cell Therapy Packaging Product and Service Providers in Europe
Table 9.5    Likely Partners for Cell Therapy Packaging Product and Service Providers in Europe
Table 9.6    Less Likely Partners for Cell Therapy Packaging Product and Service Providers in Europe
Table 9.7    Most Likely Partners for Cell Therapy Packaging Product and Service Providers in Asia Pacific and RoW
Table 9.8    Likely Partners for Cell Therapy Packaging Product and Service Providers in Asia Pacific and RoW
Table 9.9    Less Likely Partners for Cell Therapy Packaging Product and Service Providers in Asia Pacific and RoW
Table 10.1    Cell Therapy Manufacturers: List of Industry Players
Table 10.2    Cell Therapy Manufacturers: Information on Type of Cells Manufactured
Table 10.3    Cell Therapy Manufacturers: Information on Source of Cells
Table 10.4    Cell Therapy Manufacturers: Information on Scale of Operation
Table 10.5    Cell Therapy Manufacturers: Information on Type of Manufacturing Capabilities / Services
Table 13.1    Cell Therapy Packaging Service Providers: Distribution by Year of Establishment
Table 13.2    Cell Therapy Packaging Service Providers: Distribution by Company Size
Table 13.3    Cell Therapy Packaging Service Providers: Distribution by Location of Headquarters
Table 13.4    Cell Therapy Packaging Service Providers: Distribution by Package Engineering Design
Table 13.5    Cell Therapy Packaging Service Providers: Distribution by Type of Packaging
Table 13.6    Cell Therapy Packaging Service Providers: Distribution by Packaging Material
Table 13.7    Cell Therapy Packaging Service Providers: Distribution by Type of Packaging and Packaging Material
Table 13.8    Cell Therapy Packaging Service Providers: Distribution by Type of Passive System Used
Table 13.9    Cell Therapy Packaging Service Providers: Distribution by Temperature Ranges Supported
Table 13.10    Cell Therapy Packaging Service Providers: Distribution by Type of Packaging, Packaging Material and Temperature Ranges Supported
Table 13.11    Cell Therapy Packaging Service Providers: Distribution by Type of Cells Handled
Table 13.12    Cell Therapy Packaging Service Providers: Distribution by Type of Additional Services Offered
Table 13.13    Cell Therapy Packaging Products: Distribution by Type of Packaging Container
Table 13.14    Cell Therapy Packaging Products: Distribution by Container Fabrication Material
Table 13.15    Cell Therapy Packaging Products: Distribution by Type of Packaging Container and Container Fabrication Material
Table 13.16    Cell Therapy Packaging Products: Distribution by Storage Temperature Conditions
Table 13.17    Cell Therapy Packaging Products: Distribution by Type of Container and Storage Temperature Conditions
Table 13.18    Cell Therapy Packaging Products: Distribution by Type of Cells Packed
Table 13.19    Cell Therapy Packaging Products: Distribution by Usability of Container
Table 13.20    Cell Therapy Packaging Product Providers: Distribution by Year of Establishment
Table 13.21    Cell Therapy Packaging Product Providers: Distribution by Company Size
Table 13.22    Cell Therapy Packaging Product Providers: Distribution by Location of Headquarters
Table 13.23    Partnerships and Collaborations: Cumulative Year-wise Trend, 2016-2021 (till April)
Table 13.24    Partnerships and Collaborations: Distribution by Type of Partnership
Table 13.25    Partnerships and Collaborations: Distribution by Year and Type of Partnership, 2016-2021 (till April)
Table 13.26    Partnerships and Collaborations: Distribution by Purpose of Partnerships
Table 13.27    Partnerships and Collaborations: Distribution by Type of Service(s) Covered
Table 13.28    Most Active Players: Distribution by Number of Partnerships
Table 13.29    Partnerships and Collaborations: Distribution by Location of Parent Company
Table 13.30    Partnerships and Collaborations: Distribution by Location of Partner Company
Table 13.31    Partnerships and Collaborations: Distribution by Intercontinental and Intracontinental Partnerships
Table 13.32    Cell Therapy Manufacturers: Distribution by Year of Establishment
Table 13.33    Cell Therapy Manufacturers: Distribution by Company Size
Table 13.34    Cell Therapy Manufacturers: Distribution by Location of Headquarters
Table 13.35    Cell Therapy Manufacturers: Distribution by Location of Headquarters (Country Wise)
Table 13.36    Cell Therapy Manufacturers: Distribution by Location of Manufacturing Facility (Region-wise)
Table 13.37    Cell Therapy Manufacturers: Distribution by Location of Manufacturing Facility (Country-wise)
Table 13.38    Cell Therapy Manufacturers: Distribution by Type of Cells Manufactured
Table 13.39    Cell Therapy Manufacturers: Distribution by Type of Manufacturers
Table 13.40    Cell Therapy Manufacturers: Distribution by Source of Cells
Table 13.41    Cell Therapy Manufacturers: Distribution by Scale of Operation
Table 13.42    Cell Therapy Manufacturers: Distribution by Manufacturing Capabilities / Services
Table 13.43    Global Cell Therapy Packaging Services Market, 2021-2030 (USD Million)
Table 13.44    Cell Therapy Packaging Services Market for T- Cell based Therapies, 2021-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 13.45    Cell Therapy Packaging Services Market for Dendritic Cell Vaccines, 2021-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 13.46    Cell Therapy Packaging Services Market for Stem Cell Therapies, 2021-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 13.47    Cell Therapy Packaging Services Market for NK Cell Therapies, 2021-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 13.48    Cell Therapy Packaging Services Market for Other Advanced Therapy Medicinal Products, 2021-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 13.49    Cell Therapy Packaging Services Market for Primary Packaging, 2021-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 13.50    Cell Therapy Packaging Services Market for Secondary Packaging, 2021-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 13.51    Cell Therapy Packaging Services Market for Clinical Scale Operations, 2021-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 13.52    Cell Therapy Packaging Services Market for Commercial Scale Operations, 2021-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 13.53    Cell Therapy Packaging Services Market in North America, 2021-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 13.54    Cell Therapy Packaging Services Market in Europe, 2021-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 13.55    Cell Therapy Packaging Services Market in Asia Pacific, 2021-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 13.56    Cell Therapy Packaging Services Market in Rest of the World, 2021-2030: Conservative, Base and Optimistic Scenarios (USD Million)

List Of Companies

1. 3P Biopharmaceuticals
2. A2 Biotherapeutics
3. A4P
4. AbClon
5. Abeona Therapeutics
6. AccuResearch Korea
7. Achilles Therapeutics
8. Adaptimmune Therapeutics
9. Adicet Bio
10. ADVATIS
11. Advent Biologics
12. Aegle Therapeutics
13. Aeon Therapeutics
14. AffyImmune Therapeutics
15. AGC Biologics
16. AgenTus Therapeutics
17. Akron Biologics
18. Alitalia
19. Allele Biotechnology and Pharmaceuticals
20. AlLife Medicine
21. Allogene Therapeutics
22. Almac
23. Almog
24. Altaco XXI
25. Angiocrine Bioscience
26. Anterogen
27. apceth Biopharma (acquired by Hitachi Chemical)
28. Arbele
29. Arcellx
30. Aseptic Technologies
31. Aspire Health Science
32. Astellas Pharma
33. Atara Biotherapeutics
34. Athersys
35. Atlantis Bioscience
36. Aurora Biopharma
37. Asutrianova
38. Autolus Therapeutics
39. Axis Biotec
40. Azidus
41. Baylx
42. Beijing Biohealthcare Biotechnology
43. Beijing Doing Biomedical
44. Beijing Sanwater Biological Technology
45. Bellicum Pharmaceuticals
46. BHI Therapeutic Sciences
47. Bio Elpida
48. Biocair
49. BioCardia
50. Bioceltech Therapeutics
51. BioCentriq
52. BioInno Bioscience
53. Bioinova
54. BioNTech Manufacturing
55. Bioquark
56. BioRestorative Therapies
57. Biotech & Pharma Logistics
58. Biowy
59. bluebird bio
60. BlueRock Therapeutics (acquired by Bayer)
61. Bone Therapeutics
62. BrainStorm Cell Therapeutics
63. Bristol Myers Squibb
64. Brooks Life Sciences
65. Bukwang Pharmaceutical
66. Caladrius Biosciences
67. Capricor Therapeutics
68. Carina Biotech
69. CARsgen Therapeutics
70. CAR-T (Shanghai) Biotechnology 
71. Cartesian Therapeutics
72. Cartherics
73. Catalent Biologics
74. Celgene
75. Celixir
76. Cell and Gene Therapy Catapult
77. Cell Medica
78. Cell Therapies
79. CellBios
80. Cell-Easy
81. Cellectis
82. Cellerant Therapeutics
83. Cellex
84. Cellin Technologies
85. CellMP
86. CellProtect Nordic Pharmaceuticals
87. CellProthera
88. Cellular Biomedicine
89. Celonic 
90. Celularity
91. Celyad Oncology
92. CENTOGENE
93. Cesca Therapeutics
94. CHA Biotech
95. Chiesi
96. China Immunotech (Beijing) Biotechnology
97. China Regenerative Medicine
98. Chongqing Precision Biotech
99. Clean Cells
100. Co.don
101. Cognate BioServices (acquired by Charles River Laboratories)
102. CoImmune
103. ColdStash
104. Cook MyoSite
105. Cook Pharmica
106. CORESTEM    
107. Creative Biolabs
108. CRISPR Therapeutics
109. Critical Transport Solutions Australia
110. Cryo-Cell
111. CryoGene
112. CRYOPDP (acquired by Cryoport)
113. Cryoport
114. CSafe Global
115. Cynata Therapeutics
116. Cytiva
117. CytoMed Therapeutics
118. Cytopeutics
119. Cytovac
120. Dendreon Pharmaceuticals
121. DiscGenics
122. DWK Life Sciences
123. EHL Bio
124. ElevateBio
125. Eli Lilly
126. EpiBone
127. Eutilex
128. Ever Supreme Bio Technology
129. EVERSANA
130. EUMA Biotech
131. Fate Therapeutics
132. Ferrer Internacional
133. Fibrocell Science
134. Formula Pharmaceuticals
135. Fortress Biotech
136. Fosun Kite Biotechnology
137. Froceth
138. FUJIFILM Irvine Scientific
139. Gamida Cell
140. GC Cell
141. GE Healthcare
142. GenCure
143. Genenta Science
144. GenIbet Biopharmaceuticals
145. Genus Oncology
146. GigaGen
147. GlaxoSmithKline
148. Global Cell Med
149. Glycostem Therapeutics
150. Gracell Biotechnologies
151. GC Pharma
152. Greiner Bio-One
153. Gwo xi Stem Cell
154. Hebei Newtherapy BIo-Pharma technology
155. Hebei Senlang Biotechnology
156. Helix BioPharma
157. HemaCare
158. Hemostemix
159. Histocell
160. Hitachi Chemical
161. Holostem Terapie Avanzate
162. Hope Biosciences
163. Horizon Discovery
164. Hrain Biotechnology
165. iCell Gene Therapeutics
166. Icell Kealex Therapeutics
167. ICS
168. ilaya
169. Immatics
170. Immetacyte
171. Immune Therapeutics
172. Immuneel Therapeutics
173. Immunocore
174. Immunovative Therapies
175. IncoCell Tianjin
176. INNOFORCE
177. Innovative Cellular Therapeutics
178. Instant Systems
179. Instil Bio
180. Intellia Therapeutics
181. International Stem Cell
182. Invectys
183. Iovance Biotherapeutics
184. Ixaka
185. Janssen
186. Japan Regenerative Medicine
187. Japan Tissue Engineering
188. jCyte
189. Jiuzhitang Maker Cell Technology
190. Juno Therapeutics
191. Juventas Cell Therapy
192. JW Therapeutics
193. JW CreaGene
194. Kadimastem
195. KAEDI
196. Kangstem Biotech
197. KBI Biopharma
198. Kiadis Pharma
199. Kite Pharma 
200. KLSMC Stem Cells
201. KSQ Therapeutics
202. K-Stem Cell
203. Kymanox
204. Lai
205. LATAM Cargo
206. Legend Biotech
207. Leucid Bio
208. LifeCell
209. Lineage Cell Therapeutics
210. Lion TCR
211. Living Pharma
212. Longeveron
213. Lonza
214. Lufthansa Cargo
215. Lykan Bioscience
216. Macopharma
217. Magellan Biologicals
218. Magenta Therapeutics
219. Marken
220. Marker Therapeutics
221. McKesson
222. Med Cell Bahamas
223. Medeor Therapeutics
224. Medigene 
225. MEDINET
226. MEDIPOST
227. Medisix Therapeutics 
228. Melbourne Stem Cell Centre
229. Meridigen Biotech
230. Mesoblast
231. Miltenyi Biomedicine
232. Minaris Regenerative Medicine
233. Minerva Biotechnologies
234. MingJu Therapeutics
235. Minovia Therapeutics
236. MNX Global Logistics
237. MolMed
238. Müller + Müller (acquired by DWK Life Sciences)
239. Multimmune
240. Mustang Bio
241. MVE Biological Solutions
242. Nanjing Bioheng Biotech
243. NanoCool
244. NantKwest
245. Nature Cell
246. NeuroGeneration
247. NextCell Pharma
248. Nikon CeLL Innovation
249. Nipro Europe Group Companies
250. Nkarta
251. NKMax America
252. Nohla Therapeutics
253. Noile-Immune Biotech
254. Noray Biosciences Group
255. Novadip Biosciences 
256. Novartis
257. Novex Innovations
258. NuVasive
259. Obsidian Therapeutics
260. Ology Bioservices
261. Orca Bio
262. Orchard Therapeutics
263. OrganaBio
264. OriGen Biomedical
265. Orthofix
266. Osiris Therapeutics
267. Oxford Biomedica
268. PackGene Biotech
269. PACT Pharma
270. Parexel
271. Patheon
272. PeproMene Bio
273. Personalized Stem Cells
274. PersonGen BioTherapeutics
275. PharmaBio
276. Pharmicell
277. Phio Pharmaceuticals
278. Pluristem Therapeutics
279. Plus Therapeutics
280. Poseida Therapeutics
281. Precigen
282. Precision BioSciences
283. Promethera Biosciences
284. Protheragen
285. Provia Laboratories
286. Q Therapeutics
287. Quick
288. R3 Stem Cell
289. Regeneus
290. Regenexx
291. Reliance Life Sciences
292. ReNeuron
293. Riordan Technologies
294. Riyadh Pharma
295. ROHTO Pharmaceutical
296. Roslin Cell Therapies
297. Roylance Pharma
298. RTI Surgical
299. Rubius Therapeutics
300. S.Biomedics
301. SABZ Biomedicals
302. Saint-Gobain
303. Salvat
304. SanBio
305. Sangamo Therapeutics
306. SAVSU Technologies (acquired by BioLife Solutions)
307. SCHOTT
308. Sclnow Biotechnology 
309. SCM Lifescience
310. Seattle Genetics
311. Seneca Biopharma
312. Sensei Biotherapeutics
313. Sentien Biotechnologies
314. Sequel Logistics
315. Servier
316. Sexton Biotechnologies
317. SGD Pharma
318. Shandong Qilu Stem Cells Engineering
319. Shanghai Biomed-Union Biotechnology
320. Shanghai GeneChem
321. Shanghai iCELL Biotechnology
322. Shanghai Longyao Biotechnology
323. Shenzhen Binde Biotechnology
324. Shenzhen Hornetcorn Biotechnology
325. Sinobioway Cell Therapy
326. SiO2 Materials Science
327. SMT Bio
328. Sorrento Therapeutics
329. SOTIO
330. S-RACMO
331. Stem Cell Medicine
332. Stem Med
333. STEMCELL Technologies
334. Stemedica Cell Technologies
335. Steminent Biotherapeutics
336. Stemmatters
337. Stempeutics Research
338. Stryker
339. Sumitomo Dainippon Pharma
340. Suzuken
341. Swiss Medica XXI Century
342. Swiss WorldCargo
343. Tactiva Therapeutics
344. Taiwan Bio Therapeutics
345. Takara Bio
346. Takeda Pharmaceutical
347. Talaris Therapeutics
348. Targazyme
349. TC BioPharm
350. TCR2 Therapeutics
351. Technoflex
352. Teneobio
353. Terumo
354. Tessa Therapeutics
355. The Emmes Company
356. Thermo Fisher Scientific
357. Tianhe Stem Cell Biotechnologies
358. Tianjin Ever Union Biotechnology 
359. Tianjin Mycure Medical Technology
360. Tianjin Weikai Biological Engineering
361. TICEBA
362. TiGenix
363. TILT Biotherapeutics
364. time:matters
365. Timmune Biotech
366. Tissue Solutions
367. Tmunity Therapeutics
368. TPP Techno Plastic Products
369. TrakCel
370. TreeFrog Therapeutics
371. Tscan Therapeutics
372. TVAX Biomedical
373. U.S. Stem Cell
374. Ucardi Biomedical Technology
375. United Cargo
376. United Parcel Services (UPS)
377. United Therapeutics
378. University College of London
379. Unum Therapeutics
380. UWELL Biopharma
381. va-Q-tec
382. VcanBio Center for Translational Biotechnology
383. Vericel
384. VetStem Biopharma
385. ViaCyte
386. Vineti
387. Viscofan BioEngineering
388. Vitalant
389. Waisman Biomanufacturing
390. Wellington Zhaotai Therapies
391. West
392. West Biotherapy
393. World Courier
394. Wugen
395. WuXi Advanced Therapies
396. Xiangxue Life Sciences
397. Yourway
398. Zelluna Immunotherapy
399. Zumutor Biologics